BDBM297784 Ethyl 2-methyl-5-oxo-7-(piperidin-4-yl)-4,5-dihydropyrazolo[1,5-a]pyrimidine-3-carboxylate trifluoroacetate::US10118930, Example 298::US10118930, Example 9

SMILES CCOC(=O)c1c(C)nn2c(cc(=O)[nH]c12)C1CCNCC1

InChI Key InChIKey=VEMIWYWPSBUQJB-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 297784   

TargetTissue-type plasminogen activator(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM297784(US10118930, Example 9 | Ethyl 2-methyl-5-oxo-7-(pi...)
Affinity DataIC50: 33nMAssay Description:The clot-lysis test system configures the kinetics of clot formation and degradation in vitro and allows quantifying modulation of the process by sel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetTissue-type plasminogen activator(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM297784(US10118930, Example 9 | Ethyl 2-methyl-5-oxo-7-(pi...)
Affinity DataIC50: 35nMAssay Description:The clot-lysis test system configures the kinetics of clot formation and degradation in vitro and allows quantifying modulation of the process by sel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent